The Psychiatrist : Clinical and Therapeutic Journal
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Opinion   
  • Psych Clin Ther J 6;246,

The Future of Alzheimer?s Treatment: Advances in Neuroscience and Therapeutics

Chitra Kalliopi*
Department of Neurology, University of Southampton, United Kingdom
*Corresponding Author : Chitra Kalliopi, Department of Neurology, University of Southampton, United Kingdom, Email: Ahasan@gmail.com

Received Date: Apr 01, 2024 / Published Date: Apr 30, 2024

Abstract

Alzheimer’s disease (AD), a progressive neurodegenerative disorder, affects millions worldwide and remains one of the most challenging diseases to treat. Recent advances in neuroscience and therapeutics are offering new hope for slowing its progression and potentially modifying its course. This article explores the future of Alzheimer’s treatment, focusing on breakthroughs in early diagnosis, targeted drug therapies, gene editing, and innovative interventions like stem cell therapies and non-invasive brain stimulation. It also highlights the role of personalized medicine, lifestyle interventions, and the ethical considerations surrounding emerging therapies. As research accelerates, the next decade promises to reshape how we understand and combat Alzheimer’s disease, offering new possibilities for patients and caregivers

Citation: Chitra K (2024) The Future of Alzheimer’s Treatment: Advances inNeuroscience and Therapeutics. Psych Clin Ther J 6: 246.

Copyright: © 2024 Chitra K. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top